Navigation Links
GIN Introduces Advanced Robotics and Dispensing Technnology at SLAS 2013 in Orlando, FL
Date:1/14/2013

Orlando, FL (PRWEB) January 14, 2013

The increasing and growing need for pharmaceutical and biotechnology companies to speed up drug discovery and production is driving opportunities in the global laboratory automation market. This market will have reached $4.1 billion by 2015, according to Global Industry Analysts, Inc. As a solution provider to the industry, Global Innovation Network will debut the Delilah EMB dispenser at SLAS 2013. This multi-functional high accuracy and quiet dispenser has the world’s smallest footprint. The liquid handling robot increases productivity compared to traditional solutions and saves space in clean rooms and on desk tops. It has a maintenance- free operation with no wearing parts in its dispensing module. It offers extremely accurate, high- speed dispensing of up to 40 doses per second from volumes of 50 nanoliters to 140 microliters. The electromagnetic bellow patented technology offers non-contact dispensing via air and no external pressure supply is required. With full, robotic compatibility the dispenser can transform high throughput screening operations by reducing reagent costs and improving efficiency.

GIN is dedicated to introducing quality and performance driven laboratory automation products into new markets. “We facilitate the transition of cutting edge Finnish technologies into global markets by decreasing the risk. We do this by productizing the technologies and introducing the technology into the market.” says Teijo Fabritius, CEO for Global Innovation Network. The Delilah product line is a good example of this and includes sample and material handling modules that are reliable and maintenance free. In production automation, the focus of the business line is on the development of Point of Care (POC) tests and diagnostic tests manufacturing.

About Company: Global Innovation Network was founded in 2010 by a group of investors in Oulu, Finland. The private and government backed company focuses on identifying and delivering solutions in three target markets; clean tech, water purification and laboratory automation. The serial entrepreneurial team has extensive experience in global operations and a track record of highly successful exit strategies. GIN will be exhibiting at SLAS 2013 at booth #935 from January 12 – 16, 2013. Please stop by and introduce yourself. For further information please contact Matti Koivu at matti.koivu(at)go-gin(dot)com

####

Read the full story at http://www.prweb.com/releases/2013/1/prweb10319326.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
2. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
3. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
4. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
5. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
6. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
7. JPSA Introduces Picosecond Laser Micromachining System
8. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
9. AllCells Introduces Autoimmune Diseased Cells and Tissue Products
10. White Mountain Process Introduces Squeal-less Mechanical Seal
11. Zinman & Company Introduces Year-End Tax Review for Clients Using Virtual Controllership Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):